Pharmaceutical Supply – Diltiazem Hydrochloride Injection
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the supply of one unit of Diltiazem Hydrochloride Injection, a sterile cardiovascular medication, to meet specific Department of Defense requirements for packaging, labeling, and traceability. This subcontract is issued under the Defense Logistics Agency, which operates within the Department of Defense, and is classified under NAICS code 325412, indicating pharmaceutical and botanical product manufacturing. The contract was posted on July 16, 2026, and the performance location is not specified, nor are details provided about the point of contact or exact delivery address. The contract reference number SPE2DX25D9822 and delivery identifier SPE2D226F3040 are linked to a DIBBS portal where full award documentation can be accessed for further logistical or compliance details. All aspects of the product must align with military standards to ensure safe handling, accurate identification, and seamless integration into the DoD’s medical supply chain.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D226F3040.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
DILTIAZEM HYDROCHLORIDE INJECTION
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
